NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.
J Neurooncol. 2016 Oct 21;
Neuro Oncol. 2016 Nov;18(11):1472-1474
Nat Genet. 2016 Oct 10;:
Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.
Neuro Oncol. 2016 Sep 29;
A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/RTOG 9802 and 9813.
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S91
Oncotarget. 2016 Aug 29;
Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks.
Cell. 2016 Aug 11;166(4):1055
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22.
Nat Cell Biol. 2016 Aug 8;
Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas.
J Pathol Clin Res. 2015 Oct;1(4):212-24